Stuttering, treatment

Tiagabine is an anti-convulsive medication also used in the treatment for panic disorder as are a few other anticonvulsants. It does appear to operate as a selective GABA reuptake inhibitor. Tiagabine s most common side effects include confusion, difficulty speaking clearly/stuttering and mild sedation. 

Treatment with psychedelics has most often been described as ineffective in cases of hysterical neurosis and hysteria, stuttering neurosis, infantile personality, and long-term neurotic invalidism. Despite reported successes, compulsive syndromes, criminal psychopathy, and depressive states are also mentioned as contraindicated. The risks frequently have been considered too great for paranoids, severely depressed persons, outpatient psychotics and pre-psychotics, and those with a history of suicide attempts or who may be currently suicidal. However, as we have previously suggested (Masters and Houston, 1966), psychedelic therapy may be indicated in cases where suicide seems probable and imminent. By his being enabled to die symbolically and then be reborn, the patient s need to die may be subsequently eliminated. 

A 49-year-old woman had prominent stuttering before a generalized epileptic seizure and recovered after antiepileptic treatment (73). 

A 32-year-old Korean man with delusions took oral risperidone 1.0 mg/day and lorazepam 0.5 mg bd. The dose of risperidone was increased to 4 mg/day over 4 days. On day 5, he began to stutter and could not articulate what he wanted to say without stuttering. The dose of risperidone was increased to 8 mg/day and the stuttering became more pronounced. However, after 1 year of continuous treatment, he did not stutter any more. 

Morgens Hertz, a Danish physician, described a patient whose long-standing stuttering condition disappeared following LSD treatment (Stafford Golightly 1967). An American tesim of researchers found... 

Verapamil has also been used in the treatment of mania, depression, maintenance control of manic depression, and schizophrenia. In addition, it has been used in the management of premenstrual syndrome, stuttering, and intoxication with phencyclidine. 

A variety of clinical situations can result in diffuse cavernosal flbrotic changes. Low-flow priapism is a well-known cause of cavernosal tissue fibrosis with resulting venous occlusive deficiency. It is commonly accepted that prompt treatment is mandatory because recovery of erectile function becomes increasingly unlikely over time (El-Bahnasawy et al. 2002). Cavernosal tissue damage leading to fibrotic changes can occasionally occur also in patients with stuttering priapism and with arterial priapism (Hakim et al. 1996 Bertolotto et al. 2003). 

---